Home / NEWS / Top News / Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

A third fellow of a key FDA panel has resigned over the agency’s controversial decision to approve Biogen’s new Alzheimer’s drug, Aduhelm, CNBC has scholarly.

Check Also

Ponzi schemer Madoff earned $710 for almost 3,000 hours of prison work, got ‘not very dependable’ review

Bernie Madoff decreased in prison, where he was serving a 150-year sentence for running the …

Leave a Reply

Your email address will not be published. Required fields are marked *